Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » Diversity Problem Hinders Adoption of Polygenic Risk Scores, According to ESHG Panel

Diversity Problem Hinders Adoption of Polygenic Risk Scores, According to ESHG Panel

Jun 11, 2020
|
Justin Petrone

NEW YORK – Polygenic risk scores have the potential to impact cancer screening, autoimmune disease testing, and therapeutics development, but more diverse data is needed, according to several experts active in the field.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Funds Sought for Vaccine Distribution

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

Virus Variant From Spain Now Across UK

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

Unexpected Loss

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

Science Papers on Long Human-Canine Relationship, Population History of Early East Asians, More

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.

What's Popular?

In Genetic Research

  1. Qiagen, Phase Genomics Ink US Licensing Agreement for Hi-C Sequencing Technloogy

  2. COVID-19 Human Genetic Studies Presented at ASHG Point to Disease Susceptibility, Severity Loci

  3. Ancient Dog Genomes Highlight Close Relationship Between Canines, Humans

  4. Transcriptomics Data Suggest Existing Drugs Could Inhibit SARS-CoV-2

    Premium

  5. Genome of Ancient East Asian Individual Suggests Population Admixture, Denisovan Ties

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.